Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kariolis MS"'
Autor:
Reich M; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), LMU Munich, 82152 Planegg, Germany.; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany., Simon MJ; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Polke B; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Paris I; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Werner G; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Schrader C; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Spieth L; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany.; Max Planck Institute for Multidisciplinary Sciences, 37077 Göttingen, Germany., Davis SS; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Robinson S; Graduate School of Systemic Neurosciences (GSN), LMU Munich, 82152 Planegg, Germany.; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany.; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., de Melo GL; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Schlaphoff L; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Graduate School of Systemic Neurosciences (GSN), LMU Munich, 82152 Planegg, Germany.; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany., Buschmann K; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Berghoff S; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany.; Max Planck Institute for Multidisciplinary Sciences, 37077 Göttingen, Germany., Logan T; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Nuscher B; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., de Weerd L; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany., Edbauer D; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), 81377 Munich, Germany., Simons M; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany.; Institute of Neuronal Cell Biology, Technical University Munich, 80802 Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), 81377 Munich, Germany., Suh JH; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Sandmann T; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Kariolis MS; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., DeVos SL; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Paquet D; Institute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, 81377 Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), 81377 Munich, Germany., Capell A; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany., Di Paolo G; Denali Therapeutics Inc., South San Francisco, CA 94080, USA., Haass C; German Center for Neurodegenerative Diseases (DZNE), 81377 Munich, Germany.; Metabolic Biochemistry, Biomedical Centre (BMC), Faculty of Medicine, LMU Munich, 81377 Munich, Germany.; Munich Cluster for Systems Neurology (Synergy), 81377 Munich, Germany.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Jun 05; Vol. 16 (750), pp. eadj7308. Date of Electronic Publication: 2024 Jun 05.
Autor:
Logan T, Simon MJ, Rana A, Cherf GM, Srivastava A, Davis SS, Yoon Low RL, Chiu CL, Fang M, Huang F, Bhalla A, Llapashtica C, Prorok R, Pizzo ME, Calvert MEK, Sun EW, Hsiao-Nakamoto J, Rajendra Y, Lexa KW, Srivastava DB, van Lengerich B, Wang J, Robles-Colmenares Y, Kim DJ, Duque J, Lenser M, Earr TK, Nguyen H, Chau R, Tsogtbaatar B, Ravi R, Skuja LL, Solanoy H, Rosen HJ, Boeve BF, Boxer AL, Heuer HW, Dennis MS, Kariolis MS, Monroe KM, Przybyla L, Sanchez PE, Meisner R, Diaz D, Henne KR, Watts RJ, Henry AG, Gunasekaran K, Astarita G, Suh JH, Lewcock JW, DeVos SL, Di Paolo G
Publikováno v:
Cell [Cell] 2024 Mar 14; Vol. 187 (6), pp. 1565-1566.
Autor:
Chew KS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Wells RC; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Moshkforoush A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Chan D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lechtenberg KJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tran HL; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Chow J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Kim DJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Robles-Colmenares Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Srivastava DB; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tong RK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tong M; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Xa K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Yang A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Zhou Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Akkapeddi P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Annamalai L; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Bajc K; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA., Blanchette M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA., Cherf GM; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Gill A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Huynh D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Joy D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Knight KN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lac D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lexa KW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Liau NPD; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Becerra I; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Malfavon M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA., McInnes J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Nguyen HN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lozano EI; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Roche E; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Sacayon P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Calvert MEK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Daneman R; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, CA, 92093, USA., Dennis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Duque J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Gadkar K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Mahon CS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Meisner R; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA., Watts RJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Zuchero YJY; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. zuchero@dnli.com., Kariolis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. kariolis@dnli.com.
Publikováno v:
Nature communications [Nat Commun] 2023 Sep 07; Vol. 14 (1), pp. 5516. Date of Electronic Publication: 2023 Sep 07.
Autor:
Chew KS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Wells RC; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Moshkforoush A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Chan D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lechtenberg KJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tran HL; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Chow J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Kim DJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Robles-Colmenares Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Srivastava DB; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tong RK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Tong M; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Xa K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Yang A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Zhou Y; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Akkapeddi P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Annamalai L; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Bajc K; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA., Blanchette M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA., Cherf GM; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Earr TK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Gill A; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Huynh D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Joy D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Knight KN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lac D; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Leung AW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lexa KW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Liau NPD; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Becerra I; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Malfavon M; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA., McInnes J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Nguyen HN; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lozano EI; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Pizzo ME; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Roche E; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Sacayon P; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Calvert MEK; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Daneman R; Department of Pharmacology, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA.; Department of Neurosciences, University of California San Diego, 9500 Gilman Dr., La Jolla, 92093, CA, USA., Dennis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Duque J; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Gadkar K; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Lewcock JW; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Mahon CS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Meisner R; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Solanoy H; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Thorne RG; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA.; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN, USA., Watts RJ; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA., Zuchero YJY; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. zuchero@dnli.com., Kariolis MS; Denali Therapeutics, Inc., 161 Oyster Point Blvd., South San Francisco, CA, 94080, USA. kariolis@dnli.com.
Publikováno v:
Nature communications [Nat Commun] 2023 Aug 19; Vol. 14 (1), pp. 5053. Date of Electronic Publication: 2023 Aug 19.
Autor:
Arguello A; Denali Therapeutics Inc., South San Francisco, CA., Mahon CS; Denali Therapeutics Inc., South San Francisco, CA., Calvert MEK; Denali Therapeutics Inc., South San Francisco, CA., Chan D; Denali Therapeutics Inc., South San Francisco, CA., Dugas JC; Denali Therapeutics Inc., South San Francisco, CA., Pizzo ME; Denali Therapeutics Inc., South San Francisco, CA., Thomsen ER; Denali Therapeutics Inc., South San Francisco, CA., Chau R; Denali Therapeutics Inc., South San Francisco, CA., Damo LA; Denali Therapeutics Inc., South San Francisco, CA., Duque J; Denali Therapeutics Inc., South San Francisco, CA., Fang M; Denali Therapeutics Inc., South San Francisco, CA., Giese T; Denali Therapeutics Inc., South San Francisco, CA., Kim DJ; Denali Therapeutics Inc., South San Francisco, CA., Liang N; Denali Therapeutics Inc., South San Francisco, CA., Nguyen HN; Denali Therapeutics Inc., South San Francisco, CA., Solanoy H; Denali Therapeutics Inc., South San Francisco, CA., Tsogtbaatar B; Denali Therapeutics Inc., South San Francisco, CA., Ullman JC; Denali Therapeutics Inc., South San Francisco, CA., Wang J; Denali Therapeutics Inc., South San Francisco, CA., Dennis MS; Denali Therapeutics Inc., South San Francisco, CA., Diaz D; Denali Therapeutics Inc., South San Francisco, CA., Gunasekaran K; Denali Therapeutics Inc., South San Francisco, CA., Henne KR; Denali Therapeutics Inc., South San Francisco, CA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA., Sanchez PE; Denali Therapeutics Inc., South San Francisco, CA., Troyer MD; Denali Therapeutics Inc., South San Francisco, CA., Harris JM; Denali Therapeutics Inc., South San Francisco, CA., Scearce-Levie K; Denali Therapeutics Inc., South San Francisco, CA., Shan L; Denali Therapeutics Inc., South San Francisco, CA., Watts RJ; Denali Therapeutics Inc., South San Francisco, CA., Thorne RG; Denali Therapeutics Inc., South San Francisco, CA.; Department of Pharmaceutics, University of Minnesota, Minneapolis, MN., Henry AG; Denali Therapeutics Inc., South San Francisco, CA., Kariolis MS; Denali Therapeutics Inc., South San Francisco, CA.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2022 Mar 07; Vol. 219 (3). Date of Electronic Publication: 2022 Feb 28.
Autor:
Logan T; Denali Therapeutics, South San Francisco, CA, USA., Simon MJ; Denali Therapeutics, South San Francisco, CA, USA., Rana A; Denali Therapeutics, South San Francisco, CA, USA., Cherf GM; Denali Therapeutics, South San Francisco, CA, USA., Srivastava A; Denali Therapeutics, South San Francisco, CA, USA., Davis SS; Denali Therapeutics, South San Francisco, CA, USA., Low RLY; Denali Therapeutics, South San Francisco, CA, USA., Chiu CL; Denali Therapeutics, South San Francisco, CA, USA., Fang M; Denali Therapeutics, South San Francisco, CA, USA., Huang F; Denali Therapeutics, South San Francisco, CA, USA., Bhalla A; Denali Therapeutics, South San Francisco, CA, USA., Llapashtica C; Denali Therapeutics, South San Francisco, CA, USA., Prorok R; Denali Therapeutics, South San Francisco, CA, USA., Pizzo ME; Denali Therapeutics, South San Francisco, CA, USA., Calvert MEK; Denali Therapeutics, South San Francisco, CA, USA., Sun EW; Denali Therapeutics, South San Francisco, CA, USA., Hsiao-Nakamoto J; Denali Therapeutics, South San Francisco, CA, USA., Rajendra Y; Denali Therapeutics, South San Francisco, CA, USA., Lexa KW; Denali Therapeutics, South San Francisco, CA, USA., Srivastava DB; Denali Therapeutics, South San Francisco, CA, USA., van Lengerich B; Denali Therapeutics, South San Francisco, CA, USA., Wang J; Denali Therapeutics, South San Francisco, CA, USA., Robles-Colmenares Y; Denali Therapeutics, South San Francisco, CA, USA., Kim DJ; Denali Therapeutics, South San Francisco, CA, USA., Duque J; Denali Therapeutics, South San Francisco, CA, USA., Lenser M; Denali Therapeutics, South San Francisco, CA, USA., Earr TK; Denali Therapeutics, South San Francisco, CA, USA., Nguyen H; Denali Therapeutics, South San Francisco, CA, USA., Chau R; Denali Therapeutics, South San Francisco, CA, USA., Tsogtbaatar B; Denali Therapeutics, South San Francisco, CA, USA., Ravi R; Denali Therapeutics, South San Francisco, CA, USA., Skuja LL; Denali Therapeutics, South San Francisco, CA, USA., Solanoy H; Denali Therapeutics, South San Francisco, CA, USA., Rosen HJ; Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; On behalf of the ALLFTD investigators., Boeve BF; On behalf of the ALLFTD investigators; Department of Neurology, College of Medicine, Mayo Clinic, Rochester, MN, USA., Boxer AL; Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; On behalf of the ALLFTD investigators., Heuer HW; Memory and Aging Center, Department of Neurology, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; On behalf of the ALLFTD investigators., Dennis MS; Denali Therapeutics, South San Francisco, CA, USA., Kariolis MS; Denali Therapeutics, South San Francisco, CA, USA., Monroe KM; Denali Therapeutics, South San Francisco, CA, USA., Przybyla L; Denali Therapeutics, South San Francisco, CA, USA., Sanchez PE; Denali Therapeutics, South San Francisco, CA, USA., Meisner R; Denali Therapeutics, South San Francisco, CA, USA., Diaz D; Denali Therapeutics, South San Francisco, CA, USA., Henne KR; Denali Therapeutics, South San Francisco, CA, USA., Watts RJ; Denali Therapeutics, South San Francisco, CA, USA., Henry AG; Denali Therapeutics, South San Francisco, CA, USA., Gunasekaran K; Denali Therapeutics, South San Francisco, CA, USA., Astarita G; Denali Therapeutics, South San Francisco, CA, USA; Biochemistry and Molecular & Cellular Biology, Georgetown University, Washington, DC, USA., Suh JH; Denali Therapeutics, South San Francisco, CA, USA., Lewcock JW; Denali Therapeutics, South San Francisco, CA, USA., DeVos SL; Denali Therapeutics, South San Francisco, CA, USA. Electronic address: devos@dnli.com., Di Paolo G; Denali Therapeutics, South San Francisco, CA, USA. Electronic address: dipaolo@dnli.com.
Publikováno v:
Cell [Cell] 2021 Sep 02; Vol. 184 (18), pp. 4651-4668.e25. Date of Electronic Publication: 2021 Aug 26.
Autor:
Miao YR; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California., Thakkar KN; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California., Qian J; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California.; Department of Obstetrics and Gynecology, Stanford School of Medicine, Stanford, California., Kariolis MS; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California., Huang W; ChemPartner Shanghai, Shanghai, P.R. China., Nandagopal S; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California., Yang TTC; ChemPartner Shanghai, Shanghai, P.R. China., Diep AN; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California., Cherf GM; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California., Xu Y; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California., Moon EJ; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California., Xiao Y; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California.; Department of Obstetrics and Gynecology, Stanford School of Medicine, Stanford, California., Alemany H; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California., Li T; Department of Biochemistry, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, P.R. China., Yu W; Department of Biochemistry, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, P.R. China., Wei B; China PLA General Hospital, Beijing, P.R. China., Rankin EB; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California.; Department of Obstetrics and Gynecology, Stanford School of Medicine, Stanford, California., Giaccia AJ; Department of Radiation Oncology, Stanford School of Medicine, Stanford, California. giaccia@stanford.edu.; MRC Oxford Institute for Radiation Oncology, University of Oxford, Oxford OX3 7DQ, United Kingdom.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Aug 01; Vol. 27 (15), pp. 4435-4448. Date of Electronic Publication: 2021 May 19.
Autor:
Ullman JC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Arguello A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Getz JA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Bhalla A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Mahon CS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Wang J; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Giese T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Bedard C; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kim DJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Blumenfeld JR; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Liang N; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Ravi R; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Nugent AA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Davis SS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Ha C; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Duque J; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Tran HL; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Wells RC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Lianoglou S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Daryani VM; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kwan W; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Solanoy H; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Nguyen H; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Earr T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Dugas JC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Tuck MD; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Harvey JL; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Reyzer ML; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Caprioli RM; Mass Spectrometry Research Center, Vanderbilt University, 9160 MRB III, 465 21 Avenue South, Nashville, TN 37240, USA., Hall S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Poda S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sanchez PE; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Dennis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Gunasekaran K; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Srivastava A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sandmann T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Henne KR; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Thorne RG; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Di Paolo G; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Astarita G; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Diaz D; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Silverman AP; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Watts RJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sweeney ZK; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kariolis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com henry@dnli.com., Henry AG; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com henry@dnli.com.
Publikováno v:
Science translational medicine [Sci Transl Med] 2020 May 27; Vol. 12 (545).
Autor:
Kariolis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com zuchero@dnli.com., Wells RC; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Getz JA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kwan W; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Mahon CS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Tong R; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kim DJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Srivastava A; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Bedard C; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Henne KR; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Giese T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Assimon VA; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Chen X; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Zhang Y; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Solanoy H; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Jenkins K; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sanchez PE; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Kane L; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Miyamoto T; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Chew KS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Pizzo ME; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Liang N; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Calvert MEK; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., DeVos SL; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Baskaran S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Hall S; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Sweeney ZK; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Thorne RG; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Watts RJ; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Dennis MS; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Silverman AP; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA., Zuchero YJY; Denali Therapeutics Inc., 161 Oyster Point Blvd., South San Francisco, CA 94080, USA. kariolis@dnli.com zuchero@dnli.com.
Publikováno v:
Science translational medicine [Sci Transl Med] 2020 May 27; Vol. 12 (545).
Autor:
Lim S; Department of Bioengineering, ‡Institute for Stem Cell Biology and Regenerative Medicine, §Stanford Photonics Research Center, ∥Chemical Engineering, Stanford University , 450 Serra Mall, Stanford, California 94305, United States., Chen B; Department of Bioengineering, ‡Institute for Stem Cell Biology and Regenerative Medicine, §Stanford Photonics Research Center, ∥Chemical Engineering, Stanford University , 450 Serra Mall, Stanford, California 94305, United States., Kariolis MS; Department of Bioengineering, ‡Institute for Stem Cell Biology and Regenerative Medicine, §Stanford Photonics Research Center, ∥Chemical Engineering, Stanford University , 450 Serra Mall, Stanford, California 94305, United States., Dimov IK; Department of Bioengineering, ‡Institute for Stem Cell Biology and Regenerative Medicine, §Stanford Photonics Research Center, ∥Chemical Engineering, Stanford University , 450 Serra Mall, Stanford, California 94305, United States., Baer TM; Department of Bioengineering, ‡Institute for Stem Cell Biology and Regenerative Medicine, §Stanford Photonics Research Center, ∥Chemical Engineering, Stanford University , 450 Serra Mall, Stanford, California 94305, United States., Cochran JR; Department of Bioengineering, ‡Institute for Stem Cell Biology and Regenerative Medicine, §Stanford Photonics Research Center, ∥Chemical Engineering, Stanford University , 450 Serra Mall, Stanford, California 94305, United States.
Publikováno v:
ACS chemical biology [ACS Chem Biol] 2017 Feb 17; Vol. 12 (2), pp. 336-341. Date of Electronic Publication: 2016 Dec 20.